Literature DB >> 24232860

The role of different serotonin receptor subtypes in seizure susceptibility.

Mohammad Hadi Gharedaghi, Mohammad Seyedabadi, Jean-Eric Ghia, Ahmad Reza Dehpour, Reza Rahimian.   

Abstract

5-Hydroxytryptamine (5-HT) has the most diverse set of receptors in comparison with any other neurotransmitter or hormone in the body. To date, seven families of 5-HT receptors have been characterized. A great number of studies have been published regarding the role of 5-HT and its receptors in seizures. However, with a few exceptions, the net effect of activating or inhibiting each 5-HT receptor subtype on the development or severity of seizures remains controversial. Additionally, the results of studies, which have used knockout animals to investigate the role of 5-HT receptors in seizures, have sometimes been contradictory to those which have used pharmacological tools. The present study aims to review the available data regarding the influence of each receptor subtype on seizure development and, when possible, reconcile between the apparently different results obtained in these studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24232860     DOI: 10.1007/s00221-013-3757-0

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  176 in total

1.  Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.

Authors:  Elizabeth A Pehek; Christine Nocjar; Bryan L Roth; Tara A Byrd; Omar S Mabrouk
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

2.  Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

Authors:  N Ropert; N Guy
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

Review 3.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

4.  SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.

Authors:  V Di Matteo; G Di Giovanni; M Di Mascio; E Esposito
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

5.  Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy.

Authors:  Y Wada; H Hasegawa; M Nakamura; N Yamaguchi
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

6.  Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis.

Authors:  C D Applegate; L H Tecott
Journal:  Exp Neurol       Date:  1998-12       Impact factor: 5.330

7.  Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Authors:  P A Janssen; C J Niemegeers; F Awouters; K H Schellekens; A A Megens; T F Meert
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

Review 8.  5HT1F- and 5HT7-receptor agonists for the treatment of migraines.

Authors:  Reto M Agosti
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-08       Impact factor: 4.388

9.  The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy.

Authors:  K Gerber; J Filakovszky; P Halasz; G Bagdy
Journal:  Brain Res       Date:  1998-10-05       Impact factor: 3.252

10.  Effect of dotarizine on electroconvulsive shock or pentylenetetrazol-induced amnesia and on seizure reactivity in rats.

Authors:  M Lazarova; B Petkova; V D Petkov
Journal:  Methods Find Exp Clin Pharmacol       Date:  1995 Jan-Feb
View more
  12 in total

1.  Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.

Authors:  Aliesha Griffin; Kyla R Hamling; Kelly Knupp; SoonGweon Hong; Luke P Lee; Scott C Baraban
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  Serotonergic agents act on 5-HT3 receptors in the brain to block seizure-induced respiratory arrest in the DBA/1 mouse model of SUDEP.

Authors:  Carl L Faingold; Marcus Randall; Chang Zeng; Shifang Peng; Xiaoyan Long; Hua-Jun Feng
Journal:  Epilepsy Behav       Date:  2016-10-12       Impact factor: 2.937

Review 3.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 4.  The basolateral amygdala γ-aminobutyric acidergic system in health and disease.

Authors:  Eric M Prager; Hadley C Bergstrom; Gary H Wynn; Maria F M Braga
Journal:  J Neurosci Res       Date:  2015-11-19       Impact factor: 4.164

Review 5.  Serotonergic therapy in epilepsy.

Authors:  Frank G Gilliam; Hrvoje Hecimovic; Matthew S Gentry
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 5.710

Review 6.  Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

Authors:  Bruno P Guiard; Giuseppe Di Giovanni
Journal:  Front Pharmacol       Date:  2015-03-17       Impact factor: 5.810

7.  Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures.

Authors:  Marcello Venzi; François David; Joachim Bellet; Anna Cavaccini; Cristiano Bombardi; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

8.  Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish.

Authors:  Jo Sourbron; Ilse Smolders; Peter de Witte; Lieven Lagae
Journal:  Front Pharmacol       Date:  2017-04-06       Impact factor: 5.810

9.  Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Javier Garzón
Journal:  Oncotarget       Date:  2018-05-04

10.  The Role of Platelets in the Stimulation of Neuronal Synaptic Plasticity, Electric Activity, and Oxidative Phosphorylation: Possibilities for New Therapy of Neurodegenerative Diseases.

Authors:  Ekaterina Kopeikina; Eugene D Ponomarev
Journal:  Front Cell Neurosci       Date:  2021-07-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.